Header Logo

Connection

Nina Harawa to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Nina Harawa has written about Antibodies, Monoclonal, Humanized.
Nina Harawa
Connection Strength
0.050
Antibodies, Monoclonal, Humanized
  1. Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program. JAMA Intern Med. 2023 08 01; 183(8):885-889.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.